Literature DB >> 24788552

MicroRNA-26a involved in Toll-like receptor 9‑mediated lung cancer growth and migration.

De-Sheng Jiang1, Yu-Wei Wang1, Jing Jiang1, Shu-Meng Li1, Shun-Zhi Liang1, Hong-Yan Fang1.   

Abstract

Toll-like receptor 9 (TLR9) has been shown to have a significant role in cancer. MicroRNAs (miRNAs), a group of small non-coding RNAs that fine tune translation of multiple target mRNAs, are involved in the development and progression of human cancers. The present study was undertaken to determine the roles of TLR9 on lung cancer and whether miR-26a is involved in TLR9‑mediated lung cancer growth and migration. The lung cancer models were elicited by injecting human lung cancer cells into the left ventricle. The expression of TLR9 and miR-26a in lung cancer tissues obtained from lung cancer patients was increased. TLR9 ligand CpG-oligodeoxynucleotides (CpG-ODN) caused an increase in the mean tumor weight and the size of tumor mass in nude mice, and the proliferation and migration of H460 human lung cancer cells. CpG-ODN also induced an increase in the expression of miR-26a in H460 cells. The overexpression of miR-26a increased the weight and size of the tumor mass in the nude mice, and the proliferation and migration of H460 cells. Expression of phosphoinositide 3 kinase (PI3K) and phosphorylation of protein kinase B (Akt) was increased after miR-26a overexpression in the H460 cells. PI3K inhibitor wortmannin (WM) or Akt inhibitor triciribine hydrate (TCN) eliminated the increase in the proliferation and migration induced by the overexpression of miR-26a in H460 cells. These results suggested that miR-26a is involved in the TLR9‑mediated growth and migration of lung cancer through the PI3K-Akt signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788552     DOI: 10.3892/ijmm.2014.1764

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  14 in total

Review 1.  The role of microRNA-26a in human cancer progression and clinical application.

Authors:  Jing Chen; Kai Zhang; Yuejuan Xu; Yanping Gao; Chen Li; Rui Wang; Longbang Chen
Journal:  Tumour Biol       Date:  2016-04-02

2.  Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.

Authors:  K A Garbett; A Vereczkei; S Kálmán; L Wang; Ž Korade; R C Shelton; K Mirnics
Journal:  Transl Psychiatry       Date:  2015-03-10       Impact factor: 6.222

3.  Reciprocal inhibition between miR-26a and NF-κB regulates obesity-related chronic inflammation in chondrocytes.

Authors:  Qingyun Xie; Meng Wei; Xia Kang; Da Liu; Yi Quan; Xianming Pan; Xiling Liu; Dongfa Liao; Jinbiao Liu; Bo Zhang
Journal:  Biosci Rep       Date:  2015-04-25       Impact factor: 3.840

4.  miR-200c inhibits breast cancer proliferation by targeting KRAS.

Authors:  Cailu Song; Long-Zhong Liu; Xiao-Qing Pei; Xiaoping Liu; Lu Yang; Feng Ye; Xinhua Xie; Jianping Chen; Hailin Tang; Xiaoming Xie
Journal:  Oncotarget       Date:  2015-10-27

5.  Roles of toll-like receptors: From inflammation to lung cancer progression.

Authors:  Jinjing Gu; Yi Liu; Bin Xie; Pingping Ye; Jiefan Huang; Zhe Lu
Journal:  Biomed Rep       Date:  2017-12-28

Review 6.  The role of TLRs in cervical cancer with HPV infection: a review.

Authors:  Xiao Yang; Yanxiang Cheng; Chunsheng Li
Journal:  Signal Transduct Target Ther       Date:  2017-11-03

7.  MicroRNA‑26a protects vascular smooth muscle cells against H2O2‑induced injury through activation of the PTEN/AKT/mTOR pathway.

Authors:  Junlu Peng; Xinqi He; Lei Zhang; Peng Liu
Journal:  Int J Mol Med       Date:  2018-06-27       Impact factor: 4.101

8.  CircRNA-9119 suppresses poly I:C induced inflammation in Leydig and Sertoli cells via TLR3 and RIG-I signal pathways.

Authors:  Le Qin; Jie Lin; Xiaoxiao Xie
Journal:  Mol Med       Date:  2019-06-13       Impact factor: 6.354

9.  Circulating Neutrophil MicroRNAs as Biomarkers for the Detection of Lung Cancer.

Authors:  Jie Ma; Ning Li; Yanli Lin; Chhavi Gupta; Feng Jiang
Journal:  Biomark Cancer       Date:  2016-01-24

10.  Toll-like receptor expression in human non-small cell lung carcinoma: potential prognostic indicators of disease.

Authors:  Alison K Bauer; Brad L Upham; Elizabeth A Rondini; Meredith A Tennis; Kalpana Velmuragan; David Wiese
Journal:  Oncotarget       Date:  2017-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.